Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
Hemispherian has raised $1.5M in total funding. The most recent round was Grant. The last funding was announced in December 2023.
Hemispherian's investors include European Innovation Council, EIC Accelerator, Investinor, Kistefos Venture Capital, BIF Partners.
Hemispherian is headquartered in Oslo, Norway.
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
Hemispherian is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hemispherian — Funding & Investors." VCBacked, December 15, 2023, https://www.vcbacked.co/company/hemispherian. Accessed July 20, 2026.
VCBacked. (2023). Hemispherian — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/hemispherian
{{cite web |title=Hemispherian — Funding & Investors |url=https://www.vcbacked.co/company/hemispherian |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated